Report overview
Salmeterol (also known as SEREVENT) is an adrenergic receptor agonist, which is mostly prescribed for the prevention and maintenance of asthma and chronic obstructive pulmonary disease. The drug has a 12-hour duration of action and thus is more beneficial than short-acting beta2- agonists.
This report aims to provide a comprehensive presentation of the global market for Salmeterol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Salmeterol. This report contains market size and forecasts of Salmeterol in global, including the following market information:
Global Salmeterol Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Salmeterol Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Salmeterol companies in 2022 (%)
The global Salmeterol market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The increase in prevalence of people suffering from asthma and COPD, low cost of the drug, and its ability in maintaining the symptoms for long duration of time is expected to increase the demand of the drug. However, certain side-effects of the drug such as dizziness, sinus infection, migraine headaches, and breathing problems restraints the market growth.
We surveyed the Salmeterol manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Salmeterol Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salmeterol Market Segment Percentages, by Type, 2022 (%)
Asthma
Bronchospasm
COPD
Others
Global Salmeterol Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salmeterol Market Segment Percentages, by Application, 2022 (%)
Clinical Research Institutes
Hospital
Surgical Centers
Others
Global Salmeterol Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Salmeterol Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Salmeterol revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Salmeterol revenues share in global market, 2022 (%)
Key companies Salmeterol sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Salmeterol sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Lupin Limited
MidasCare
Teva Pharmaceutical Industries
GlaxoSmithKline
Intas Pharmaceuticals
NATCO Pharma Limited
INVENT FARMA HOLDING SPAIN
Mylan
Redwing Pharma
Axa Parenterals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Salmeterol, market overview.
Chapter 2: Global Salmeterol market size in revenue and volume.
Chapter 3: Detailed analysis of Salmeterol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Salmeterol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Salmeterol capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
